Overview * WELL Health ( WHTCF ) Q3 revenue grows 56% yr/yr but misses analyst expectations * Adjusted EBITDA for Q3 rises 296% to C$59.9 mln * Company reaffirms annual revenue and adjusted EBITDA guidance Outlook * WELL reaffirms 2025 revenue guidance of C$1.40 bln to C$1.45 bln * Company expects 2025 Adjusted EBITDA in upper half of C$190 mln...

Overview * Achieve Q3 net loss and EPS missed analyst expectations * FDA accepted NDA for cytisinicline in smoking cessation, PDUFA date set for June 2026 * Awarded FDA Commissioner's National Priority Voucher for vaping cessation Outlook * Company confirms PDUFA action date for cytisinicline as June 20, 2026 * Achieve awarded FDA Priority Voucher for vaping cessation * Company...

07:31 AM EST, 11/06/2025 (MT Newswires) -- Viatris ( VTRS ) reported Q3 adjusted earnings Thursday of $0.67 per share, down from $0.75 a year earlier. Analysts polled by FactSet expected $0.62. Revenue for the quarter ended Sept. 30 was $3.76 billion, compared with $3.75 billion a year earlier. Analysts surveyed by FactSet expected $3.62 billion. For 2025, the company...

Overview * Middleby ( MIDD ) Q3 revenue grows 4% yr/yr, beating analyst expectations * Adjusted EPS for Q3 rises to $2.37, surpassing prior year's $2.33 * Company announces strategic review of Residential Kitchen business, incurs $709 mln impairment Outlook * Company expects Q4 revenue of $990-1,020 mln * Middleby ( MIDD ) forecasts Q4 adjusted EBITDA of $200-210 mln...